The impact of biomedical innovation on medication non-adherence

In collaboration with: Columbia Business School, Columbia University; DocMorris​​​​​​​

Abstract

Medication non-adherence has been identified as substantial source of waste across health care systems. In this project, we study the influence of pharmaceutical innovation on adherence behavior in the working population in Germany and the United States. We focus on analyses of chronic conditions using real world data on drug utilization.

Here is a short thread of the results via Twitter

References

Blankart, K. E., & Lichtenberg, F. R. (2020). Are patients more adherent to newer drugs? Health Care Management Science. https://doi.org/10.1007/s10729-020-09513-5